Success Story: Overcoming an RFE: Bioengineering Expert Secures I-140 NIW Approval for Research Advancing Healthcare Technology
Client’s Testimonial:
“Thank you very much! I truly appreciate all your help and support throughout the process.”
On August 6th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Research Scholar in the Field of Bioengineering (Approval Notice).
General Field: Bioengineering
Position at the Time of Case Filing: Research Scholar
Country of Origin: Egypt
Country of Residence at the Time of Filing: Louisiana
Approval Notice Date: August 6th, 2026
Processing Time: 24 months, 22 days (Premium Processing Upgrade Requested)
Case Summary:
With a Ph.D. in computer science and engineering and expertise in bioengineering, the client has built a research career at the intersection of computational methods and healthcare applications. The client’s work focuses broadly on developing intelligent biomedical technologies that can support earlier and more effective diagnosis while helping reduce healthcare burdens. We were pleased to help the client secure approval of an I-140 National Interest Waiver (NIW) petition after responding to a Request for Evidence (RFE).
Applying Advanced Computing to Healthcare Challenges
The client’s proposed endeavor centers on advancing computational tools for biomedical applications through artificial intelligence, machine learning, and related data-driven methods. Rather than presenting this work as a collection of highly specialized projects, we demonstrated how the client’s broader research direction could contribute to more accessible and effective diagnostic technologies and improved healthcare outcomes.
We positioned the endeavor as nationally important by connecting its potential healthcare benefits with the broader U.S. interest in advancing emerging technologies. We also documented that research associated with the client’s work had received support from major U.S. government funding sources. This funding provided an additional objective indicator of institutional interest in research addressing scientific and healthcare priorities.
Building a Record of Independent Research Influence
To demonstrate that the client was well-positioned to advance the proposed endeavor, we presented a record extending beyond academic training alone. At the time of filing, the client had produced:
- 3 peer-reviewed journal articles, including 1 first-authored article
- 3 peer-reviewed conference papers, including 1 first-authored and 1 co-first-authored paper
- 1 first-authored book chapter
- 1 co-first-authored abstract
- 1 granted patent
- 57 citations to the client’s publications
These numbers were not presented as sufficient by themselves. Instead, we explained what they revealed about the client’s standing in the field. Independent researchers had cited and relied on the client’s work in subsequent studies, showing that the research had moved beyond publication and contributed to the work of other scholars.
We further highlighted that one of the client’s articles ranked among the top 10% most-cited computer science articles from its year of publication. This provided comparative context for the citation record and helped demonstrate that the influence of the client’s work was notable relative to similarly situated research.
Expert Endorsements
Four letters of recommendation were submitted in support of the case. These letters provided expert perspectives on the client’s technical expertise, prior research contributions, and ability to continue advancing work with broader scientific and healthcare value. One expert noted:
“The success of his past research foreshadows the importance of his continued work in the United States.”
From RFE to NIW Approval
Following the RFE, the case ultimately resulted in I-140 NIW approval. The case was built around a connected evidentiary record rather than isolated numerical achievements. The approval represents an important step for the client to continue pursuing bioengineering research that applies advanced computational technologies to healthcare challenges in the United States.